Native Mass Spectrometry Reveals Binding Interactions of SARS-CoV-2 PLpro with Inhibitors and Cellular Targets

被引:0
|
作者
James, Virginia K. [1 ]
Godula, Rianna N. [2 ]
Perez, Jessica M. [2 ]
Beckham, Josh T. [3 ]
Butalewicz, Jamie P. [1 ]
Sipe, Sarah N. [1 ]
Huibregtse, Jon M. [2 ]
Brodbelt, Jennifer S. [1 ]
机构
[1] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA
[2] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA
[3] Univ Texas Austin, Freshman Res Initiat, Austin, TX 78712 USA
来源
ACS INFECTIOUS DISEASES | 2024年 / 10卷 / 10期
基金
美国国家卫生研究院;
关键词
ultraviolet photodissociation; mass spectrometry; SARS-CoV protease; PLpro; inhibitor; protein-protein interactions; CROSS-LINKING; DISTANCE RESTRAINTS; PAPAIN-LIKE; PROTEIN; PR-619;
D O I
10.1021/acsinfecdis.4c00444
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Here we used native mass spectrometry (native MS) to probe a SARS-CoV protease, PLpro, which plays critical roles in coronavirus disease by affecting viral protein production and antagonizing host antiviral responses. Ultraviolet photodissociation (UVPD) and variable temperature electrospray ionization (vT ESI) were used to localize binding sites of PLpro inhibitors and revealed the stabilizing effects of inhibitors on protein tertiary structure. We compared PLpro from SARS-CoV-1 and SARS-CoV-2 in terms of inhibitor and ISG15 interactions to discern possible differences in protease function. A PLpro mutant lacking a single cysteine was used to localize inhibitor binding, and thermodynamic measurements revealed that inhibitor PR-619 stabilized the folded PLpro structure. These results will inform further development of PLpro as a therapeutic target against SARS-CoV-2 and other emerging coronaviruses.
引用
收藏
页码:3597 / 3606
页数:10
相关论文
共 50 条
  • [1] Inhibitors of SARS-CoV-2 PLpro
    Calleja, Dale J.
    Lessene, Guillaume
    Komander, David
    FRONTIERS IN CHEMISTRY, 2022, 10
  • [2] Mass spectrometry reveals potential of β-lactams as SARS-CoV-2 Mpro inhibitors
    Malla, Tika R.
    Tumber, Anthony
    John, Tobias
    Brewitz, Lennart
    Strain-Damerell, Claire
    Owen, C. David
    Lukacik, Petra
    Chan, H. T. Henry
    Maheswaran, Pratheesh
    Salah, Eidarus
    Duarte, Fernanda
    Yang, Haitao
    Rao, Zihe
    Walsh, Martin A.
    Schofield, Christopher J.
    CHEMICAL COMMUNICATIONS, 2021, 57 (12) : 1430 - 1433
  • [3] Discovery of PLpro and Mpro Inhibitors for SARS-CoV-2
    Puhl, Ana C.
    Godoy, Andre S.
    Noske, Gabriela D.
    Nakamura, Aline M.
    Gawriljuk, Victor O.
    Fernandes, Rafaela S.
    Oliva, Glaucius
    Ekins, Sean
    ACS OMEGA, 2023, 8 (25): : 22603 - 22612
  • [4] Advances in the Search for SARS-CoV-2 Mpro and PLpro Inhibitors
    Diogo, Marcel Arruda
    Cabral, Augusto Gomes Teixeira
    de Oliveira, Renata Barbosa
    PATHOGENS, 2024, 13 (10):
  • [5] Applications of Machine Learning Approaches for the Discovery of SARS-CoV-2 PLpro Inhibitors
    Pal, Sourav
    Nance, Kellie D.
    Joshi, Dirgha Raj
    Kales, Stephen C.
    Ye, Lin
    Hu, Xin
    Shamim, Khalida
    Zakharov, Alexey V.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2025, 65 (03) : 1338 - 1356
  • [6] Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity
    Shen, Zhengnan
    Ratia, Kiira
    Cooper, Laura
    Kong, Deyu
    Lee, Hyun
    Kwon, Youngjin
    Li, Yangfeng
    Alqarni, Saad
    Huang, Fei
    Dubrovskyi, Oleksii
    Rong, Lijun
    Thatcher, Gregory R. J.
    Xiong, Rui
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 2940 - 2955
  • [7] Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2
    Patel, Dhaval
    Athar, Mohd
    Jha, P. C.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (07): : 3071 - 3081
  • [8] SARS-CoV-2: the many pros of targeting PLpro
    Christopher B. McClain
    Nicolas Vabret
    Signal Transduction and Targeted Therapy, 5
  • [9] SARS-CoV-2: the many pros of targeting PLpro
    McClain, Christopher B.
    Vabret, Nicolas
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [10] Phytocompounds as potential inhibitors of SARS-CoV-2 Mpro and PLpro through computational studies
    Rudrapal, Mithun
    Celik, Ismail
    Chinnam, Sampath
    Ansari, Mohammad Azam
    Khan, Johra
    Alghamdi, Saad
    Almehmadi, Mazen
    Zothantluanga, James H.
    Khairnar, Shubham J.
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2022, 29 (05) : 3456 - 3465